|
2024-01-08 |
2024-01-05 |
PS
Planned sale
|
Brockstedt Dirk G.
CHIEF SCIENTIFIC OFFICER
Officer
|
898
-3.1%
22.78
USD 20,456
|
898
-3.1%
|
22.78
|
USD 20,456
|
|
|
2023-12-22 |
2023-12-21 |
PS
Planned sale
|
HO WILLIAM
Chief Medical Officer
Officer
|
2,500
-14.3%
21.68
USD 54,200
|
2,500
-14.3%
|
21.68
|
USD 54,200
|
|
|
2023-11-29 |
2023-11-28 |
PS
Planned sale
|
HO WILLIAM
Chief Medical Officer
Officer
|
1,500
-7.9%
13.72
USD 20,580
|
1,500
-7.9%
|
13.72
|
USD 20,580
|
|
|
2023-10-04 |
2023-10-03 |
PS
Planned sale
|
HO WILLIAM
Chief Medical Officer
Officer
|
2,500
-11.7%
15.77
USD 39,425
|
2,500
-11.7%
|
15.77
|
USD 39,425
|
|
|
2023-08-22 |
2023-08-18 |
PS
Planned sale
|
HO WILLIAM
Chief Medical Officer
Officer
|
2,500
-10.5%
18.92
USD 47,300
|
2,500
-10.5%
|
18.92
|
USD 47,300
|
|
|
2023-04-20 |
2023-04-19 |
PS
Planned sale
|
HO WILLIAM
Chief Medical Officer
Officer
|
5,000
-19.2%
18.88
USD 94,400
|
5,000
-19.2%
|
18.88
|
USD 94,400
|
|
|
2023-03-15 |
2023-03-14 |
B
Purchase
|
Robbins Wendye
Non-Executive Director
|
2,500
+62.5%
20.05
USD 50,125
|
2,500
+62.5%
|
20.05
|
USD 50,125
|
|
|
2023-03-15 |
2023-03-14 |
B
Purchase
|
Robbins Wendye
Non-Executive Director
|
600
+4.2%
19.95
USD 11,970
|
600
+4.2%
|
19.95
|
USD 11,970
|
|
|
2023-03-15 |
2023-03-14 |
B
Purchase
|
Robbins Wendye
Non-Executive Director
|
400
+2.9%
18.48
USD 7,392
|
400
+2.9%
|
18.48
|
USD 7,392
|
|
|
2023-03-15 |
2023-03-14 |
B
Purchase
|
Robbins Wendye
Non-Executive Director
|
1,500
+12.1%
18.75
USD 28,125
|
1,500
+12.1%
|
18.75
|
USD 28,125
|
|
|
2023-03-13 |
2023-03-07 |
PS
Planned sale
|
HO WILLIAM
Chief Medical Officer
Officer
|
5,000
-16.4%
29.62
USD 148,100
|
5,000
-16.4%
|
29.62
|
USD 148,100
|
|
|
2023-01-26 |
2023-01-24 |
PS
Planned sale
|
HO WILLIAM
Chief Medical Officer
Officer
|
5,000
-14.3%
30.00
USD 150,000
|
5,000
-14.3%
|
30.00
|
USD 150,000
|
|
|
2023-01-20 |
2023-01-19 |
PS
Planned sale
|
HO WILLIAM
Chief Medical Officer
Officer
|
5,000
-12.5%
25.56
USD 127,800
|
5,000
-12.5%
|
25.56
|
USD 127,800
|
|
|
2023-01-09 |
2023-01-05 |
S
Sale
|
Brockstedt Dirk G.
Chief Scientific Officer
Officer
|
742
-3.7%
21.97
USD 16,299
|
742
-3.7%
|
21.97
|
USD 16,299
|
|
|
2022-12-30 |
2022-12-29 |
PS
Planned sale
|
HO WILLIAM
Chief Medical Officer
Officer
|
5,000
-11.7%
18.03
USD 90,150
|
5,000
-11.7%
|
18.03
|
USD 90,150
|
|
|
2022-11-29 |
2022-11-28 |
PS
Planned sale
|
HO WILLIAM
Chief Medical Officer
Officer
|
5,000
-10.5%
17.87
USD 89,350
|
5,000
-10.5%
|
17.87
|
USD 89,350
|
|
|
2022-11-03 |
2022-11-02 |
PS
Planned sale
|
HO WILLIAM
Chief Medical Officer
Officer
|
5,000
-9.5%
22.32
USD 111,600
|
5,000
-9.5%
|
22.32
|
USD 111,600
|
|
|
2022-10-14 |
2022-10-13 |
PS
Planned sale
|
HO WILLIAM
Chief Medical Officer
Officer
|
2,000
-3.7%
21.52
USD 43,040
|
2,000
-3.7%
|
21.52
|
USD 43,040
|
|
|
2022-08-31 |
2022-08-30 |
PS
Planned sale
|
HO WILLIAM
Chief Medical Officer
Officer
|
2,500
-4.5%
28.13
USD 70,325
|
2,500
-4.5%
|
28.13
|
USD 70,325
|
|
|
2022-07-13 |
2022-07-11 |
S
Sale
|
HO WILLIAM
Chief Medical Officer
Officer
|
2,000
-3.7%
19.95
USD 39,900
|
2,000
-3.7%
|
19.95
|
USD 39,900
|
|
|
2022-05-27 |
2022-05-25 |
B
Purchase
|
COLUMN GROUP II, LP
Large shareholder
|
63
+0.1%
12.45
USD 785
|
63
+0.1%
|
12.45
|
USD 785
|
|
|
2022-05-27 |
2022-05-25 |
B
Purchase
|
COLUMN GROUP II, LP
Large shareholder
|
1,837
+0.1%
12.45
USD 22,880
|
1,837
+0.1%
|
12.45
|
USD 22,880
|
|
|
2022-05-27 |
2022-05-25 |
B
Purchase
|
COLUMN GROUP II, LP
Large shareholder
|
63
+0.1%
12.45
USD 785
|
63
+0.1%
|
12.45
|
USD 785
|
|
|
2022-05-27 |
2022-05-25 |
B
Purchase
|
COLUMN GROUP II, LP
Large shareholder
|
1,837
+0.1%
12.45
USD 22,880
|
1,837
+0.1%
|
12.45
|
USD 22,880
|
|
|
2022-05-25 |
2022-05-24 |
B
Purchase
|
COLUMN GROUP II, LP
Large shareholder
|
538
+1.3%
12.00
USD 6,457
|
538
+1.3%
|
12.00
|
USD 6,457
|
|
|
2022-05-25 |
2022-05-24 |
B
Purchase
|
COLUMN GROUP II, LP
Large shareholder
|
15,776
+1.3%
12.00
USD 189,345
|
15,776
+1.3%
|
12.00
|
USD 189,345
|
|
|
2022-05-25 |
2022-05-24 |
B
Purchase
|
COLUMN GROUP II, LP
Large shareholder
|
538
+1.3%
12.00
USD 6,457
|
538
+1.3%
|
12.00
|
USD 6,457
|
|
|
2022-05-25 |
2022-05-24 |
B
Purchase
|
COLUMN GROUP II, LP
Large shareholder
|
15,776
+1.3%
12.00
USD 189,345
|
15,776
+1.3%
|
12.00
|
USD 189,345
|
|
|
2022-05-25 |
2022-05-23 |
B
Purchase
|
COLUMN GROUP II, LP
Large shareholder
|
338
+0.8%
12.50
USD 4,225
|
338
+0.8%
|
12.50
|
USD 4,225
|
|
|
2022-05-25 |
2022-05-23 |
B
Purchase
|
COLUMN GROUP II, LP
Large shareholder
|
9,898
+0.8%
12.50
USD 123,718
|
9,898
+0.8%
|
12.50
|
USD 123,718
|
|
|
2022-05-25 |
2022-05-23 |
B
Purchase
|
COLUMN GROUP II, LP
Large shareholder
|
338
+0.8%
12.50
USD 4,225
|
338
+0.8%
|
12.50
|
USD 4,225
|
|
|
2022-05-25 |
2022-05-23 |
B
Purchase
|
COLUMN GROUP II, LP
Large shareholder
|
9,898
+0.8%
12.50
USD 123,718
|
9,898
+0.8%
|
12.50
|
USD 123,718
|
|
|
2022-05-12 |
2022-05-10 |
B
Purchase
|
COLUMN GROUP II, LP
Large shareholder
|
41,250
+inf%
10.67
USD 440,199
|
41,250
+inf%
|
10.67
|
USD 440,199
|
|
|
2022-05-12 |
2022-05-10 |
B
Purchase
|
COLUMN GROUP II, LP
Large shareholder
|
1,208,750
+inf%
10.67
USD 12,899,176
|
1,208,750
+inf%
|
10.67
|
USD 12,899,176
|
|
|
2022-05-12 |
2022-05-10 |
B
Purchase
|
Robbins Wendye
Non-Executive Director
|
400
+11.1%
10.62
USD 4,248
|
400
+11.1%
|
10.62
|
USD 4,248
|
|
|
2022-05-12 |
2022-05-10 |
B
Purchase
|
Robbins Wendye
Non-Executive Director
|
600
+20.0%
10.49
USD 6,294
|
600
+20.0%
|
10.49
|
USD 6,294
|
|
|
2022-05-12 |
2022-05-10 |
B
Purchase
|
Robbins Wendye
Non-Executive Director
|
1,000
+50.0%
10.51
USD 10,510
|
1,000
+50.0%
|
10.51
|
USD 10,510
|
|
|
2022-05-12 |
2022-05-10 |
B
Purchase
|
Robbins Wendye
Non-Executive Director
|
500
+38.5%
11.30
USD 5,650
|
500
+38.5%
|
11.30
|
USD 5,650
|
|
|
2022-05-12 |
2022-05-10 |
B
Purchase
|
Robbins Wendye
Non-Executive Director
|
2,500
+22.1%
11.80
USD 29,500
|
2,500
+22.1%
|
11.80
|
USD 29,500
|
|
|
2022-05-12 |
2022-05-10 |
B
Purchase
|
Robbins Wendye
Non-Executive Director
|
2,000
+21.5%
10.54
USD 21,080
|
2,000
+21.5%
|
10.54
|
USD 21,080
|
|
|
2022-05-12 |
2022-05-10 |
PP
Planned purchase
|
Young Rodney KB
Chief Financial Officer
Officer
|
5,000
+98.3%
10.53
USD 52,650
|
5,000
+98.3%
|
10.53
|
USD 52,650
|
|
|
2022-05-12 |
2022-05-10 |
B
Purchase
|
COLUMN GROUP II, LP
Large shareholder
|
41,250
+inf%
10.67
USD 440,199
|
41,250
+inf%
|
10.67
|
USD 440,199
|
|
|
2022-05-12 |
2022-05-10 |
B
Purchase
|
COLUMN GROUP II, LP
Large shareholder
|
1,208,750
+inf%
10.67
USD 12,899,176
|
1,208,750
+inf%
|
10.67
|
USD 12,899,176
|
|
|
2022-05-05 |
2022-05-04 |
PS
Planned sale
|
Brockstedt Dirk G.
Chief Scientific Officer
Officer
|
720
-3.5%
15.05
USD 10,836
|
720
-3.5%
|
15.05
|
USD 10,836
|
|
|
2022-04-12 |
2022-04-11 |
PS
Planned sale
|
Brockstedt Dirk G.
Chief Scientific Officer
Officer
|
2,647
-11.8%
23.05
USD 61,013
|
2,647
-11.8%
|
23.05
|
USD 61,013
|
|
|
2022-04-07 |
2022-04-06 |
PS
Planned sale
|
HO WILLIAM
Chief Medical Officer
Officer
|
3,000
-5.3%
22.96
USD 68,880
|
3,000
-5.3%
|
22.96
|
USD 68,880
|
|
|
2022-03-14 |
2022-03-11 |
PS
Planned sale
|
Brockstedt Dirk G.
Chief Scientific Officer
Officer
|
2,648
-11.8%
23.91
USD 63,314
|
2,648
-11.8%
|
23.91
|
USD 63,314
|
|
|
2022-02-28 |
2022-02-28 |
PS
Planned sale
|
HO WILLIAM
Chief Medical Officer
Officer
|
3,000
-5.1%
18.79
USD 56,370
|
3,000
-5.1%
|
18.79
|
USD 56,370
|
|
|
2022-02-14 |
2022-02-11 |
PS
Planned sale
|
Brockstedt Dirk G.
Chief Scientific Officer
Officer
|
2,647
-11.8%
22.47
USD 59,478
|
2,647
-11.8%
|
22.47
|
USD 59,478
|
|
|
2022-01-14 |
2022-01-13 |
PS
Planned sale
|
HO WILLIAM
Chief Medical Officer
Officer
|
3,000
-4.9%
30.67
USD 92,010
|
3,000
-4.9%
|
30.67
|
USD 92,010
|
|
|
2022-01-13 |
2022-01-11 |
PS
Planned sale
|
Brockstedt Dirk G.
Chief Scientific Officer
Officer
|
2,648
-11.8%
32.16
USD 85,160
|
2,648
-11.8%
|
32.16
|
USD 85,160
|
|
|
2022-01-06 |
2022-01-05 |
PS
Planned sale
|
HO WILLIAM
Chief Medical Officer
Officer
|
2,000
-3.2%
40.00
USD 80,000
|
2,000
-3.2%
|
40.00
|
USD 80,000
|
|
|
2021-12-13 |
2021-12-10 |
PS
Planned sale
|
Brockstedt Dirk G.
Chief Scientific Officer
Officer
|
2,647
-11.8%
30.88
USD 81,739
|
2,647
-11.8%
|
30.88
|
USD 81,739
|
|
|
2021-12-06 |
2021-12-03 |
PS
Planned sale
|
HO WILLIAM
Chief Medical Officer
Officer
|
3,000
-5.0%
32.26
USD 96,780
|
3,000
-5.0%
|
32.26
|
USD 96,780
|
|
|
2021-12-10 |
2021-11-11 |
PS
Planned sale
|
Brockstedt Dirk G.
Chief Scientific Officer
Officer
|
2,648
-11.8%
35.69
USD 94,507
|
2,648
-11.8%
|
35.69
|
USD 94,507
|
|
|
2021-10-19 |
2021-10-18 |
B
Purchase
|
Robbins Wendye
Non-Executive Director
|
500
+5.7%
30.70
USD 15,350
|
500
+5.7%
|
30.70
|
USD 15,350
|
|
|
2021-10-15 |
2021-10-13 |
B
Purchase
|
Robbins Wendye
Non-Executive Director
|
400
+4.8%
29.69
USD 11,876
|
400
+4.8%
|
29.69
|
USD 11,876
|
|
|
2021-10-14 |
2021-10-13 |
PS
Planned sale
|
HO WILLIAM
Chief Medical Officer
Officer
|
3,000
-4.8%
29.69
USD 89,070
|
3,000
-4.8%
|
29.69
|
USD 89,070
|
|
|
2021-10-12 |
2021-10-11 |
PS
Planned sale
|
Brockstedt Dirk G.
Chief Scientific Officer
Officer
|
2,647
-11.8%
30.78
USD 81,475
|
2,647
-11.8%
|
30.78
|
USD 81,475
|
|
|
2021-09-29 |
2021-09-27 |
S
Sale
|
COLUMN GROUP II, LP
Large shareholder
|
625
-100.0%
34.94
USD 21,840
|
625
-100.0%
|
34.94
|
USD 21,840
|
|
|
2021-09-29 |
2021-09-27 |
S
Sale
|
COLUMN GROUP II, LP
Large shareholder
|
1,114
-100.0%
34.97
USD 38,951
|
1,114
-100.0%
|
34.97
|
USD 38,951
|
|
|
2021-09-29 |
2021-09-27 |
S
Sale
|
COLUMN GROUP II, LP
Large shareholder
|
7,500
-100.0%
34.48
USD 258,606
|
7,500
-100.0%
|
34.48
|
USD 258,606
|
|
|
2021-09-14 |
2021-09-13 |
S
Sale
|
COLUMN GROUP II, LP
Large shareholder
|
4,788
-11.6%
35.28
USD 168,942
|
4,788
-11.6%
|
35.28
|
USD 168,942
|
|
|
2021-09-14 |
2021-09-13 |
S
Sale
|
COLUMN GROUP II, LP
Large shareholder
|
4,726
-6.1%
35.27
USD 166,692
|
4,726
-6.1%
|
35.27
|
USD 166,692
|
|
|
2021-09-14 |
2021-09-13 |
S
Sale
|
COLUMN GROUP II, LP
Large shareholder
|
4,803
-6.2%
35.25
USD 169,309
|
4,803
-6.2%
|
35.25
|
USD 169,309
|
|
|
2021-09-14 |
2021-09-10 |
S
Sale
|
COLUMN GROUP II, LP
Large shareholder
|
7,231
-14.9%
35.19
USD 254,494
|
7,231
-14.9%
|
35.19
|
USD 254,494
|
|
|
2021-09-14 |
2021-09-10 |
S
Sale
|
COLUMN GROUP II, LP
Large shareholder
|
7,320
-8.7%
35.19
USD 257,573
|
7,320
-8.7%
|
35.19
|
USD 257,573
|
|
|
2021-09-14 |
2021-09-10 |
S
Sale
|
COLUMN GROUP II, LP
Large shareholder
|
7,187
-8.5%
35.19
USD 252,940
|
7,187
-8.5%
|
35.19
|
USD 252,940
|
|
|
2021-09-13 |
2021-09-10 |
PS
Planned sale
|
Brockstedt Dirk G.
Chief Scientific Officer
Officer
|
2,648
-11.8%
35.78
USD 94,745
|
2,648
-11.8%
|
35.78
|
USD 94,745
|
|
|
2021-06-21 |
2021-06-16 |
B
Purchase
|
Robbins Wendye
Non-Executive Director
|
5
+1.7%
31.61
USD 158
|
5
+1.7%
|
31.61
|
USD 158
|
|
|
2021-06-21 |
2021-06-16 |
B
Purchase
|
Robbins Wendye
Non-Executive Director
|
100
+1.5%
31.53
USD 3,153
|
100
+1.5%
|
31.53
|
USD 3,153
|
|
|
2021-06-21 |
2021-06-16 |
B
Purchase
|
Robbins Wendye
Non-Executive Director
|
100
+1.5%
31.56
USD 3,156
|
100
+1.5%
|
31.56
|
USD 3,156
|
|
|
2021-06-21 |
2021-06-16 |
B
Purchase
|
Robbins Wendye
Non-Executive Director
|
500
+8.2%
31.54
USD 15,770
|
500
+8.2%
|
31.54
|
USD 15,770
|
|
|
2021-06-17 |
2021-06-15 |
PS
Planned sale
|
HO WILLIAM
Chief Medical Officer
Officer
|
1,000
-1.7%
43.26
USD 43,260
|
1,000
-1.7%
|
43.26
|
USD 43,260
|
|
|
2021-06-15 |
2021-06-11 |
PS
Planned sale
|
Brockstedt Dirk G.
Chief Scientific Officer
Officer
|
2,647
-11.8%
18.55
USD 49,102
|
2,647
-11.8%
|
18.55
|
USD 49,102
|
|
